Author

W. Tse

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

H. JIA· 1 shared H. Q. V. KOH· 1 shared J. E. Park· 1 shared J. Lescar· 1 shared J. LIM· 1 shared J. Y. G. NGAN· 1 shared K. PETHE· 1 shared K. S. Sze· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

H. JIA

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HflX controls hypoxia-induced non-replicating persistence in slow growing mycobacteria

J. Y. G. NGAN, S. PASUNOOTI, W. TSE, W. MENG, S. F. C. NGAN, S. W. NG, M. T. JAAFAR, H. JIA, S. L. S. CHO, J. LIM, H. Q. V. KOH, N. ABDULGHANI, K. PETHE, K. S. Sze, J. Lescar, S. Alonso

This study shows HflX in slow-growing mycobacteria enables hypoxia-induced non-replicating persistence, contributing to drug tolerance and dormancy.

bioRxiv · Mar 13, 2020 · PreprintMicrobiology

ERO1α promotes hypoxic tumour progression and is associated with poor prognosis in pancreatic cancer

N. Gupta, J. E. Park, W. Tse, L. J. Kim, O. L. Kon, N. E. McCarthy, S. K. Sze

This study identifies ERO1α as a key driver of hypoxic pancreatic tumour progression and poor prognosis, supported by proteomic analysis and functional validation.

bioRxiv · Jun 6, 2019Cancer Biology